A. H. Khan and J. E. Pessin, Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways, Diabetologia, vol.45, pp.1475-1483, 2002.

E. D. Rosen and B. M. Spiegelman, Adipocytes as regulators of energy balance and glucose homeostasis, Nature, vol.444, pp.847-853, 2006.

E. E. Kershaw and J. S. Flier, Adipose tissue as an endocrine organ, J. Clin. Endocrinol. Metab, vol.89, pp.2548-2556, 2004.

Y. H. Lee and R. E. Pratley, The evolving role of inflammation in obesity and the metabolic syndrome, Curr. Diab. Rep, vol.5, pp.70-75, 2005.

A. S. Greenberg and M. S. Obin, Obesity and the role of adipose tissue in inflammation and metabolism, Am. J. Clin. Nutr, vol.83, pp.461-465, 2006.

E. Maury and S. M. Brichard, Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome, Mol. Cell. Endocrinol, vol.314, pp.1-16, 2010.

B. G. Marques, D. B. Hausman, and R. J. Martin, Association of fat cell size and paracrine growth factors in development of hyperplastic obesity, Am. J. Phys, vol.275, pp.1898-1908, 1998.

N. Palau, S. A. Rebuffat, J. Altirriba, S. Piquer, F. A. Hanzu et al., Role of IGFBP-3 in the regulation of beta-cell mass during obesity: adipose tissue/ beta-cell cross talk, Endocrinology, vol.153, pp.177-187, 2012.

S. A. Rebuffat, J. M. Oliveira, J. Altirriba, N. Palau, A. Garcia et al., Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat, Diabetologia, vol.56, pp.2446-2455, 2013.

M. Claret, H. Corominola, I. Canals, J. Saura, S. Barcelo-batllori et al., Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation, vol.146, pp.4362-4369, 2005.

M. Asfari, D. Janjic, P. Meda, G. Li, P. A. Halban et al., Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines, Endocrinology, vol.130, pp.167-178, 1992.

M. Shiota and R. L. Printz, Diabetes in Zucker diabetic fatty rat, vol.933, pp.103-123, 2012.

C. S. Nunemaker, H. G. Chung, G. M. Verrilli, K. L. Corbin, A. Upadhye et al., Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function, J. Endocrinol, vol.222, pp.267-276, 2014.

B. P. Sampey, A. M. Vanhoose, H. M. Winfield, A. J. Freemerman, M. J. Muehlbauer et al., Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet, Obesity (Silver Spring), vol.19, pp.1109-1117, 2011.

C. Chavey, B. Mari, M. N. Monthouel, S. Bonnafous, P. Anglard et al., Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation, J. Biol. Chem, vol.278, pp.11888-11896, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00089110

H. B. Jones, D. Nugent, and R. Jenkins, Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains, Int. J. Exp. Pathol, vol.91, pp.288-301, 2010.

J. S. Yudkin, E. Eringa, and C. D. Stehouwer, Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease, Lancet, vol.365, pp.1817-1820, 2005.

P. Bostrom, J. Wu, M. P. Jedrychowski, A. Korde, L. Ye et al., A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis, Nature, vol.481, pp.463-468, 2012.

T. L. Jetton, J. Lausier, K. Larock, W. E. Trotman, B. Larmie et al., Mechanisms of compensatory beta-cell growth in insulinresistant rats: roles of Akt kinase, vol.54, pp.2294-2304, 2005.

N. Rasouli and P. A. Kern, Adipocytokines and the metabolic complications of obesity, J. Clin. Endocrinol. Metab, vol.93, pp.64-73, 2008.

C. N. Lumeng, Innate immune activation in obesity, Mol. Asp. Med, vol.34, pp.12-29, 2013.

M. Y. Donath, Targeting inflammation in the treatment of type 2 diabetes: time to start, Nat. Rev. Drug Discov, vol.13, pp.465-476, 2014.

J. Diana and A. Lehuen, Macrophages and beta-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes, EMBO Mol. Med, vol.6, pp.1090-1104, 2014.

S. M. Sajadi, H. Khoramdelazad, G. Hassanshahi, H. Rafatpanah, J. Hosseini et al., Plasma levels of CXCL1 (GRO-alpha) and CXCL10 (IP-10) are elevated in type 2 diabetic patients: evidence for the involvement of inflammation and angiogenesis/angiostasis in this disease state, Clin. Lab, vol.59, pp.133-137, 2013.

M. C. Oliveira, Z. Menezes-garcia, M. C. Henriques, F. M. Soriani, V. Pinho et al., Acute and sustained inflammation and metabolic dysfunction induced by high refined carbohydrate-containing diet in mice, Obesity (Silver Spring), vol.21, pp.396-406, 2013.

C. Chavey, G. Lazennec, S. Lagarrigue, C. Clape, I. Iankova et al., CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance, vol.9, pp.339-349, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00375507

F. M. Qureshi, E. A. Dejene, K. L. Corbin, and C. S. Nunemaker, Stress-induced dissociations between intracellular calcium signaling and insulin secretion in pancreatic islets, Cell Calcium, vol.57, pp.366-375, 2015.

L. A. Borg and D. L. Eizirik, Short-term exposure of rat pancreatic islets to human interleukin-1 beta increases cellular uptake of calcium, Immunol. Lett, vol.26, pp.253-258, 1990.

G. A. Spinas, J. P. Palmer, T. Mandrup-poulsen, H. Andersen, J. H. Nielsen et al., The bimodal effect of interleukin 1 on rat pancreatic beta-cells-stimulation followed by inhibition-depends upon dose, duration of exposure, and ambient glucose concentration, Acta Endocrinol, vol.119, pp.307-311, 1988.